ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,144.15
0.24%
US Tech 100
21,553.60
-0.10%
다우존스 지수
44,627.59
0.16%
Bitcoin
96,884.98
0.26%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Neurogene Inc (NGNE) 시세

Neurogene Inc

Neurogene Inc (NGNE)

NASDAQ
16.97
-0.38
(-2.19%)
마감 20 2월 6:00AM
15분 지연
16.97
0.00
(0.00%)
시간외 거래: 9:50AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
16.97
매수가
15.98
매도가
17.40
거래량
242,710
16.96 일간 변동폭 17.80
14.42 52주 범위 74.49
market_cap
252.085M
전일 종가
17.35
개장가
17.07
최근 거래 시간
15
@
16.72
마지막 거래 시간
재정 규모
US$ 4,223,431
VWAP
17.4011
평균 볼륨(3m)
275,719
발행 주식
14,854,725
배당수익률
-
주가수익률
-6.95
주당순이익(EPS)
-2.44
매출
-
순이익
-36.32M

Neurogene Inc 정보

Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional ge... Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.neoleukin.com
본부
Wilmington, Delaware, USA
설립됨
-
Neurogene Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker NGNE. The last closing price for Neurogene was US$17.35. Over the last year, Neurogene shares have traded in a share price range of US$ 14.42 to US$ 74.49.

Neurogene currently has 14,854,725 shares in issue. The market capitalisation of Neurogene is US$257.73 million. Neurogene has a price to earnings ratio (PE ratio) of -6.95.

NGNE 최신 뉴스

추가 뉴스
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.28-1.623188405817.2519.9716.9511848818.23289614CS
40.664.0465971796416.3126.479914.4228692818.91589385CS
12-10.17-37.472365512227.1427.440414.4227571921.24584606CS
26-18.53-52.197183098635.574.4914.4227666929.81708249CS
52-12.01-41.442374051128.9874.4914.4220543132.66162006CS
1562.416.472203157214.5774.4912.4918754132.32337587CS
2602.416.472203157214.5774.4912.4918754132.32337587CS

NGNE - Frequently Asked Questions (FAQ)

What is the current Neurogene share price?
The current share price of Neurogene is US$ 16.97
How many Neurogene shares are in issue?
Neurogene has 14,854,725 shares in issue
What is the market cap of Neurogene?
The market capitalisation of Neurogene is USD 257.73M
What is the 1 year trading range for Neurogene share price?
Neurogene has traded in the range of US$ 14.42 to US$ 74.49 during the past year
What is the PE ratio of Neurogene?
The price to earnings ratio of Neurogene is -6.95
What is the reporting currency for Neurogene?
Neurogene reports financial results in USD
What is the latest annual profit for Neurogene?
The latest annual profit of Neurogene is USD -36.32M
What is the registered address of Neurogene?
The registered address for Neurogene is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19802
What is the Neurogene website address?
The website address for Neurogene is www.neoleukin.com
Which industry sector does Neurogene operate in?
Neurogene operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 10.1006
(148.78%)
149.38M
EDITEditas Medicine Inc
US$ 3.19
(83.33%)
49.89M
SINTSiNtx Technologies Inc
US$ 4.79
(69.86%)
70.97M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.363
(63.07%)
215.48M
AGHAureus Greenway Holdings Inc
US$ 3.8501
(42.07%)
1.02M
CNSPCNS Pharmaceuticals Inc
US$ 0.0838
(-41.19%)
88.17M
HCTIHealthcare Triangle Inc
US$ 0.4409
(-38.76%)
3.19M
NKLANikola Corporation
US$ 0.4711
(-38.49%)
110.5M
BPTHBio Path Holdings Inc
US$ 0.1322
(-37.05%)
2.14M
GLSTUGlobal Star Acquisition Inc
US$ 7.26
(-36.04%)
4.41k
ADTXAditxt Inc
US$ 0.1288
(17.09%)
612.1M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0616
(13.03%)
482.51M
SMCISuper Micro Computer Inc
US$ 60.25
(7.97%)
338.03M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.363
(63.07%)
215.48M
NVDANVIDIA Corporation
US$ 139.23
(-0.12%)
168.03M

NGNE Discussion

게시물 보기
Monksdream Monksdream 5 월 전
NGNE volatile stock
👍️0
LegendaryNomad22 LegendaryNomad22 8 월 전
Weird. Both TSHA and NGNE have gene therapy candidates for Rett and both of them tanked today, despite sharing strong interim results. There's an International Rett Syndrome Foundation meeting today and tomorrow, so I wonder if something happened there to take the wind out of the gene therapy treatment class. Anyone have any knowledge here?
👍️0
Monksdream Monksdream 11 월 전
NGNE new 52 hi
👍️0

최근 히스토리

NASDAQ
NGNE
Neurogene
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지